cytotoxic ribonucleases (Immunomedics/NCI)

N/A

Report date: 2025/03/18 20:00:05

Base Information

Drug Namecytotoxic ribonucleases (Immunomedics/NCI)

Drug Alias NameRNAse conjugate (Immunomedics/NCI)antibody-conjugated cytotoxic ribonucleases (Immunomedics/NCI)anticancer agents (Immunomedics/NCI)

ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzymeBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Monoclonal antibody conjugate

Mechanisms of ActionEnzymes stimulants

TargetsEnzymes

Therapy Area/IndicationsLymphoma, Non-HodgkinNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesImmunomedics Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesImmunomedics Inc

Active IndicationsN/A

Inactive IndicationsLymphoma, Non-HodgkinNeoplasms

Other Information

ATC CodeN/A